Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS)

被引:179
|
作者
Barrea, Luigi [1 ]
Arnone, Angela [1 ]
Annunziata, Giuseppe [2 ]
Muscogiuri, Giovanna [1 ]
Laudisio, Daniela [1 ]
Salzano, Ciro [1 ]
Pugliese, Gabriella [1 ]
Colao, Annamaria [1 ]
Savastano, Silvia [1 ]
机构
[1] Univ Naples Federico II, Med Sch Naples, Dipartimento Med Clin & Chirurg, Unit Endocrinol, Via Sergio Pansini 5, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dept Pharm, Via Domenico Montesano 49, I-80131 Naples, Italy
关键词
Mediterranean Diet; Dietary pattern; Body Composition; Phase Angle; Polycystic Ovary Syndrome (PCOS); Nutritionist; BIOELECTRICAL-IMPEDANCE ANALYSIS; POPULATION REFERENCE VALUES; PHASE-ANGLE; INSULIN-RESISTANCE; CLINICAL SEVERITY; OLIVE OIL; FAT; INFLAMMATION; GROWTH; MASS;
D O I
10.3390/nu11102278
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Polycystic ovary syndrome (PCOS) is the most common female endocrine disorder and is characterized by chronic anovulation, hyperandrogenism, and polycystic ovaries. Obesity, low-grade chronic inflammatory status, and insulin-resistance (IR) often coexist in PCOS. The Mediterranean diet (MD) is an anti-inflammatory dietary pattern, which is rich in complex carbohydrates and fiber, and high in monounsaturated fat. There is a close association among obesity, low-grade chronic inflammation, IR, and hormonal derangements in PCOS. The main aim of the present study was to evaluate the adherence to MD, the dietary intake, and the body composition and their association with PCOS clinical severity in a cohort of treatment-naive women with PCOS when compared with a control group of healthy women matched for age and body mass index (BMI). In this case-controlled, cross-sectional study, we enrolled 112 patients with PCOS and 112 controls. PREvencion con DIetaMEDiterranea (PREDIMED) and seven-day food records were used to evaluate the degree of adherence to the MD and dietary pattern, respectively. Body composition was evaluated by bioelectrical impedance analysis (BIA) phase-sensitive system. Testosterone levels and Ferriman-Gallwey score assessed the clinical severity of PCOS. C-reactive protein (CRP) levels were determined with a nephelometric assay with CardioPhase high sensitivity. PCOS women showed higher testosterone levels, Ferriman-Gallwey score, fasting insulin and glucose levels, and Homeostatic Model Assessment (HoMA)-IR when compared with the control group (p < 0.001). In addition, we found that the PCOS women consumed less extra-virgin olive oil, legumes, fish/seafood, and nuts compared with control group. Despite no differences in energy intake between the two groups, the PCOS women consumed a lower quantity of complex carbohydrate, fiber, monounsaturated fatty acids (MUFA), and n-3 polyunsaturated fatty acid (PUFA), and higher quantity of simple carbohydrate, total fat, saturated fatty acid (SFA), PUFA and n-6 PUFA than the control group. The PCOS women have an adverse body composition when compared with controls, with the lowest values of phase angle (PhA) and fat-free mass (p < 0.001). Additionally, after adjusting for BMI and total energy intake, testosterone levels showed significant negative correlations with PREDIMED score (p < 0.001) and consumption of protein (p = 0.005), complex carbohydrate (p < 0.001), fiber (p < 0.001), MUFA (p < 0.001), n-3 PUFA (p = 0.001), and positive associations with CRP levels, simple carbohydrate, SFA, n-6 PUFA (p < 0.001, respectively), and PUFA (p = 0.002). The cut-off for PREDIMED score <= 6 (p < 0.001, area under the curve (AUC) 0.848, standard error 0.036, 95% confidence interval (CI) 0.768 to 0.909) could serve as a threshold for significantly increased risk of high value of testosterone levels. In conclusion, a novel direct association between the adherence to MD and the clinical severity of the disease was reported in women with PCOS. This association could support a therapeutic role of foods and nutrients of the Mediterranean dietary pattern in the PCOS pathogenesis likely involving their inflammatory status, IR, and hyperandrogenemia. In addition, we reported a different body composition that is characterized by lower PhA and fat-free mass than controls. These data suggested a role of PhA as a useful marker of the clinical severity of this syndrome and provided strong evidence regarding the strategic relevance of the nutritional assessment in the management of women with PCOS.
引用
收藏
页数:21
相关论文
共 50 条
  • [41] Body Composition and Its Impact on the Hormonal Disturbances in Women with Polycystic Ovary Syndrome
    Bizon, Anna
    Placzkowska, Sylwia
    Niepsuj, Justyna
    Czwojdzinska, Marta
    Lesniewski, Marcin
    Nowak, Artur
    Pluta, Dagmara
    Madej, Pawel
    Piwowar, Agnieszka
    Franik, Grzegorz
    NUTRIENTS, 2021, 13 (12)
  • [42] Bane mineral density and body composition in lean women with polycystic ovary syndrome
    Good, C
    Tuchinsky, M
    Mauger, D
    Demers, LM
    Legro, RS
    FERTILITY AND STERILITY, 1999, 72 (01) : 21 - 25
  • [43] Polycystic ovary syndrome (PCOS) in adolescence
    Ibáñez, L
    PROCEEDINGS OF THE 12TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY, 2004, : 169 - 173
  • [44] Dietary intake, glucose metabolism and sex hormones in women with polycystic ovary syndrome (PCOS) compared with women with non-PCOS-related infertility
    Tsai, Ya-Hui
    Wang, Ting-Wen
    Wei, Hsiao-Jui
    Hsu, Chien-Yeh
    Ho, Hsin-Jung
    Chen, Wen-Hua
    Young, Robert
    Liaw, Chian-Mey
    Chao, Jane C. -J.
    BRITISH JOURNAL OF NUTRITION, 2013, 109 (12) : 2190 - 2198
  • [45] MYO-inositol in the treatment of women with polycystic ovary syndrome (PCOS)
    Orbetzova, Maria
    Koleva, Daniela
    Mitkov, Mitko
    Pehlivanov, Blagovest
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 137 - 137
  • [46] Standardized Mortality Rate in Parents of Women with the Polycystic Ovary Syndrome (PCOS).
    Louwers, Yvonne V.
    Roest-Schalken, Marieke
    Roeters-van Lennep, Jeanine
    Sijbrands, Eric J.
    Laven, Joop S. E.
    REPRODUCTIVE SCIENCES, 2012, 19 (S3) : 207A - 207A
  • [47] The Diagnostic Experiences of Women With Polycystic Ovary Syndrome (PCOS) in Ontario, Canada
    Soucie, Kendall
    Samardzic, Tanja
    Schramer, Kristin
    Ly, Cindy
    Katzman, Rachel
    QUALITATIVE HEALTH RESEARCH, 2021, 31 (03) : 523 - 534
  • [48] BONE METABOLIC PARAMETERS IN YOUNG WOMEN WITH POLYCYSTIC OVARY SYNDROME (PCOS)
    Csupor, Emoke
    Acs, Bence
    Acs, Orsolya
    Ferencz, Viktoria
    Meszaros, Szilvia
    Toth, Edit
    Horvath, Csaba
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 310 - 310
  • [49] The role of obesity in the development of polycystic ovary syndrome (PCOS) in Iraqi women
    Obaid, Reem M.
    MEDICAL SCIENCE, 2019, 23 (98) : 565 - 570
  • [50] Incidence of dyslipidemia and hyperinsulinemia in women diagnosed with polycystic ovary syndrome (PCOS).
    Scharnowski, SD
    Minjarez, D
    FERTILITY AND STERILITY, 2001, 76 (03) : S31 - S31